[Polaris Group] March 2026 Revenue NT$2M (YoY -59.7%)
Biopharmaceutical company Polaris Group (code: 6550) reported monthly revenue of NT$1.57 million for March 2026, a 59.7% decrease year-on-year, likely reflecting the progress of clinical trials and the pre-product launch stage.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: April 12, 2026 at 16:30 (1015h 30m after Published)
- 🤖 AI Analyzed: April 13, 2026 at 10:56 (18h 26m after Collected)
Company Code: 6550
Company Name: Polaris Group
Industry: Biotechnology and Medical Care
Data Month: 2026-03
Monthly Revenue: 1,578 thousand NTD (1.58 million)
Year-on-Year Change: -59.7%
Company Name: Polaris Group
Industry: Biotechnology and Medical Care
Data Month: 2026-03
Monthly Revenue: 1,578 thousand NTD (1.58 million)
Year-on-Year Change: -59.7%